What is INCR's current stock price?

INCR (InterCure Ltd.) is currently trading at $0.88 with a market cap of $48.0M.

What sector is InterCure Ltd. in?

InterCure Ltd. (INCR) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.

InvestLog

INCR InterCure Ltd.

Healthcare

$0.88+3.27%ClosedMarket Cap: $48.0M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

0.39

P/S

0.79

EV/EBITDA

-8.77

DCF Value

$-2.99

FCF Yield

6.1%

Div Yield

0.0%

Margins & Returns

Gross Margin

21.7%

Operating Margin

-17.8%

Net Margin

-19.5%

ROE

-8.8%

ROA

-5.3%

ROIC

-4.8%

Financials

View All

Period	Revenue	Net Income	EPS
FY null	$270.2M	$-35.7M	$—
Q2 null	$65.0M	$-852.0K	$—
Q1 null	$65.0M	$-852.0K	$—
Q4 null	$56.6M	$-34.6M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

2 Strong Buy6 Buy4 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All

Rabinovich Alexanderdirector, officer: Chief Executive Officer

SellMon Apr 20

Rabinovich Alexanderdirector, officer: Chief Executive Officer

SellMon Apr 20

Rabinovich Alexanderdirector, officer: Chief Executive Officer

SellMon Apr 20

Michelson Lennie Grinbaumdirector

SellMon Apr 20

Michelson Lennie Grinbaumdirector

SellMon Apr 20

Company Info

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Exchange

—

Beta

1.11

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.

Peers